VX-35

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameVX-35

Drug Alias Nameanti-C35 antibody (Vaccinex)125I-anti-C35 (Vaccinex)C35-based therapies (Vaccinex)iodine-125-anti-C35 (Vaccinex)C-35 +[7]

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVaccinex Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaccinex Inc

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A